| Revenue growth | 19% YoY for FY26. |
|---|---|
| Margins | Gross margin compressed to 56% vs 63% FY25. |
| Demand visibility | High for Maize (+54% volume) and Paddy (+25%). |
| Management confidence | Strong international expansion outlook. |
Growth
FY26 Revenue grew 19% YoY to ₹4,316 Mn; EBITDA remained flat at ₹525 Mn; PAT declined 8% to ₹384 Mn.
Outlook
Uzbekistan expansion contributed ₹15 Cr milestone; Cotton-Paddy portfolio share increased to 58%.
Risks
PNS segment declined 19% due to China export restrictions; Vegetable Seeds volume down 15%.
Earnings Call filed with NSE, NSE: NATHBIOGEN. Summary written with AI assistance from the document.
Nath Bio-Genes (India) Ltd: key numbers
- Share price
- ₹149.35
- Market cap
- ₹283.8 Cr
- Revenue (annual)
- ₹445.1 Cr
- Net profit (annual)
- ₹41.63 Cr
- P/E (TTM)
- 7.8×Sector 29.0×
- Promoter holding
- 45.60%+0.00% QoQ
- FII holding
- 0.26%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Nath Bio-Genes (India) Ltd
All →Nath Bio-Genes (India) Annual General Meeting
Nath Bio-Genes (India) Ltd held its 33rd AGM on September 24, 2026. Shareholders approved all five resolutions, including a final dividend of ₹2/- per share.
Nath Bio-Genes (India) Investor Presentation: Key Takeaways
Nath Bio-Genes reported strong Q1 FY27 results with Revenue and EBITDA growing 15% and 17% YoY respectively. The company continues to focus on high-yield cotton, maize, and paddy seeds.
Nath Bio-Genes (India) Q1 FY27 Results: Net Profit ₹32.3 Cr, Up 14.1% YoY
Nath Bio-Genes (India) Ltd reported revenue from operations of ₹328.4 Cr (+15.8% YoY) and net profit of ₹32.3 Cr (+14.1% YoY) for Q1 FY27.
- Key figure
- Net profit ₹32.3 Cr · +14.1% YoY
Nath Bio-Genes (India) Earnings Call: Key Takeaways
Nath Bio-Genes reported FY26 revenue of ₹4,316M (up 19% YoY) with an EBITDA of ₹525M. Management is diversifying into non-cotton, non-paddy segments (NCD) and international markets like Uzbekistan.
Nath Bio-Genes (India) Earnings Call: Key Takeaways
Nath Bio-Genes reported FY26 revenue of ₹4,316 Mn, a 19% YoY increase, driven by strong growth in Cotton, Paddy, and Maize segments. Strategy focuses on R&D, product diversification, and international expansion.
Nath Bio-Genes (India) Q4 FY26 Results: Net Profit ₹0 Cr
Nath Bio-Genes (India) Ltd reported revenue from operations of ₹51.6 Cr (-0.6% YoY) and net profit of ₹0 Cr for Q4 FY26.
- Key figure
- Net profit ₹0 Cr